Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024
Compare Balance Sheet Results of Samrat Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.09
20.00
-16.91
-84.55%
Share Warrants & Outstandings
Total Reserve
68.71
2.22
66.49
2,995.05%
Shareholder's Funds
71.80
22.22
49.58
223.13%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
4.20
-4.20
-100.00%
Secured Loans
0.00
4.20
-4.20
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.11
0.87
-0.76
-87.36%
Other Long Term Liabilities
0.00
2.73
-2.73
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.19
-0.19
-100.00%
Total Non-Current Liabilities
0.11
7.99
-7.88
-98.62%
Current Liabilities
Trade Payables
38.70
2.62
36.08
1,377.10%
Other Current Liabilities
0.94
0.08
0.86
1,075.00%
Short Term Borrowings
9.91
0.71
9.20
1,295.77%
Short Term Provisions
0.02
0.15
-0.13
-86.67%
Total Current Liabilities
49.58
3.56
46.02
1,292.70%
Total Liabilities
121.49
33.77
87.72
259.76%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
16.85
24.84
-7.99
-32.17%
Less: Accumulated Depreciation
6.37
4.97
1.40
28.17%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
10.48
19.87
-9.39
-47.26%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
3.44
0.00
3.44
0.00%
Long Term Loans & Advances
0.75
2.26
-1.51
-66.81%
Other Non Current Assets
3.46
0.76
2.70
355.26%
Total Non-Current Assets
18.13
22.89
-4.76
-20.80%
Current Assets Loans & Advances
Current Investments
0.36
0.00
0.36
0.00%
Inventories
38.01
2.44
35.57
1,457.79%
Sundry Debtors
56.54
3.21
53.33
1,661.37%
Cash and Bank
0.16
1.16
-1.00
-86.21%
Other Current Assets
0.17
0.00
0.17
0.00%
Short Term Loans and Advances
8.13
4.07
4.06
99.75%
Total Current Assets
103.36
10.88
92.48
850.00%
Net Current Assets (Including Current Investments)
53.78
7.32
46.46
634.70%
Total Current Assets Excluding Current Investments
103.00
10.88
92.12
846.69%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
121.49
33.77
87.72
259.76%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
9.91
4.91
5.00
101.83%
Book Value per share (adjusted)
232.39
11.11
221.28
1,991.72%
Annual - Borrowings
Borrowings 9.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 10.48 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Annual - Investments
Investments 3.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Annual - Current Assets
Current Assets 103.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024






